These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31303024)

  • 1. Using AB Designs With Nonoverlap Effect Size Measures to Support Clinical Decision-Making: A Monte Carlo Validation.
    Giannakakos AR; Lanovaz MJ
    Behav Modif; 2023 Nov; 47(6):1407-1422. PubMed ID: 31303024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power analysis for single-case designs: Computations for (AB)
    Hedges LV; Shadish WR; Natesan Batley P
    Behav Res Methods; 2023 Oct; 55(7):3494-3503. PubMed ID: 36223007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance criteria-based effect size (PCES) measurement of single-case experimental designs: A real-world data study.
    Aydin O; Tanious R
    J Appl Behav Anal; 2022 Jun; 55(3):891-918. PubMed ID: 35593661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conditional power of randomization tests for single-case effect sizes in designs with randomized treatment order: A Monte Carlo simulation study.
    Michiels B; Heyvaert M; Onghena P
    Behav Res Methods; 2018 Apr; 50(2):557-575. PubMed ID: 28389851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Single-Case Designs in Practical Settings: Is Within-Subject Replication Always Necessary?
    Lanovaz MJ; Turgeon S; Cardinal P; Wheatley TL
    Perspect Behav Sci; 2019 Mar; 42(1):153-162. PubMed ID: 31976426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized single-case AB phase designs: Prospects and pitfalls.
    Michiels B; Onghena P
    Behav Res Methods; 2019 Dec; 51(6):2454-2476. PubMed ID: 30022457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a Visual Structured Criterion for the Analysis of Alternating-Treatment Designs.
    Lanovaz MJ; Cardinal P; Francis M
    Behav Modif; 2019 Jan; 43(1):115-131. PubMed ID: 29094610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting a Within- or Between-Subject Design for Mediation: Validity, Causality, and Statistical Power.
    Montoya AK
    Multivariate Behav Res; 2023; 58(3):616-636. PubMed ID: 35679239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABkPowerCalculator: An App to Compute Power for Balanced (AB)
    Batley P; Thamaran M; Hedges LV
    Multivariate Behav Res; 2024; 59(2):406-410. PubMed ID: 37847706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedural sensitivities of effect sizes for single-case designs with directly observed behavioral outcome measures.
    Pustejovsky JE
    Psychol Methods; 2019 Apr; 24(2):217-235. PubMed ID: 29911874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian group sequential designs for phase III emergency medicine trials: a case study using the PARAMEDIC2 trial.
    Ryan EG; Stallard N; Lall R; Ji C; Perkins GD; Gates S
    Trials; 2020 Jan; 21(1):84. PubMed ID: 31937351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.
    Kurland BF; Doot RK; Linden HM; Mankoff DA; Kinahan PE
    Clin Trials; 2013; 10(6):886-95. PubMed ID: 24169628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety interventions for the prevention of accidents at work: A systematic review.
    Dyreborg J; Lipscomb HJ; Nielsen K; Törner M; Rasmussen K; Frydendall KB; Bay H; Gensby U; Bengtsen E; Guldenmund F; Kines P
    Campbell Syst Rev; 2022 Jun; 18(2):e1234. PubMed ID: 36911341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining nonoverlap and trend for single-case research: Tau-U.
    Parker RI; Vannest KJ; Davis JL; Sauber SB
    Behav Ther; 2011 Jun; 42(2):284-99. PubMed ID: 21496513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Permutation Distancing Test for dependent single-case observational AB-phase design data: A Monte Carlo simulation study.
    Vroegindeweij A; Nijhof LN; Onghena P; van de Putte EM; Nijhof SL; Houtveen J
    Behav Res Methods; 2024 Mar; 56(3):2569-2580. PubMed ID: 37528291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
    Ryan EG; Brock K; Gates S; Slade D
    BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deployment of personnel to military operations: impact on mental health and social functioning.
    Bøg M; Filges T; Jørgensen AMK
    Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical power for the two-factor repeated measures ANOVA.
    Potvin PJ; Schutz RW
    Behav Res Methods Instrum Comput; 2000 May; 32(2):347-56. PubMed ID: 10875184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waiting for baseline stability in single-case designs: Is it worth the time and effort?
    Lanovaz MJ; Primiani R
    Behav Res Methods; 2023 Feb; 55(2):843-854. PubMed ID: 35469087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.